Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Circulation|May 20, 1998
Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GP IIb/IIIa receptor blockadeM A Mascelli, E T Lance, L Damaraju, et al.
NPJ Primary Care Respiratory Medicine|January 5, 2020
Accuracy of Vitalograph lung monitor as a screening test for COPD in primary careA P Dickens, D A Fitzmaurice, P Adab, et al.
Blood|August 1, 1996
Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human plateletsC L Wagner, M A Mascelli, D S Neblock, et al.
Thrombosis and Haemostasis|May 25, 2001
7E3 F(ab')2, an effective antagonist of rat alphaIIbbeta3 and alphavbeta3, blocks in vivo thrombus formation and in vitro angiogenesisP M Sassoli, E L Emmell, S H Tam, et al.
Journal of Thrombosis and Thrombolysis|December 10, 1999
Ticlopidine enhances the platelet inhibitory capacity of abciximab in vitroN S Kleiman, N Graziadei, R E Jordan, et al.
NPJ Primary Care Respiratory Medicine|November 25, 2018
Systematic review of the effectiveness of community-based self-management interventions among primary care COPD patientsK Jolly, M S Sidhu, E Bates, et al.
Circulation|December 24, 1997
Rapid assessment of platelet function with a modified whole-blood aggregometer in percutaneous transluminal coronary angioplasty patients receiving anti-GP IIb/IIIa therapyM A Mascelli, S Worley, N J Veriabo, et al.
American Heart Journal|July 1, 1999
Readministration of abciximab: interim report of the ReoPro readministration registryJ E Tcheng, D J Kereiakes, G A Braden, et al.
Circulation|February 18, 1997
Effects of GP IIb/IIIa receptor monoclonal antibody (7E3), heparin, and aspirin in an ex vivo canine arteriovenous shunt model of stent thrombosisR R Makkar, F Litvack, N L Eigler, et al.
American Heart Journal|August 31, 2000
Abciximab, ticlopidine, and concomitant abciximab-ticlopidine therapy: ex vivo platelet aggregation inhibition profiles in patients undergoing percutaneous coronary interventionsN S Kleiman, N Grazeiadei, K Maresh, et al.
Pageof 6